Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-06-07 Sale | 2022-06-08 4:03 pm | FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director | 841 | $21.89 | $18,409 | 1,840 (Direct) | View |
2022-06-03 Sale | 2022-06-06 4:40 pm | FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director | 807 | $22.8 | $18,400 | 1,874 (Direct) | View |
2022-02-07 Sale | 2022-02-09 5:40 pm | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 1,058 | $1.5 | $1,587 | 156,385 (Direct) | View |
2022-02-02 Sale | 2022-02-04 4:15 pm | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 2,639 | $1.37 | $3,615 | 157,443 (Direct) | View |
2022-01-26 Sale | 2022-01-28 4:15 pm | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 2,922 | $2.02 | $5,902 | 160,082 (Direct) | View |
2021-12-06 Sale | 2021-12-07 7:03 pm | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 1,780 | $2.93 | $5,215 | 163,004 (Direct) | View |
2021-02-04 Sale | 2021-02-05 4:41 pm | Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer | 969 | $11.21 | $10,862 | 104,341 (Direct) | View |
2021-01-25 Sale | 2021-01-27 8:38 pm | Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer | 2,872 | $11.41 | $32,770 | 75,727 (Direct) | View |
2020-12-03 Sale | 2020-12-07 07:00 am | Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer | 2,522 | $13.54 | $34,148 | 76,089 (Direct) | View |
2020-06-26 Sale | 2020-06-30 08:56 am | Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer | 1,805 | $16.15 | $29,151 | 78,611 (Direct) | View |
2020-03-25 Sale | 2020-03-26 9:00 pm | Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer | 1,243 | $15.28 | $18,993 | 71,991 (Direct) | View |
2020-01-24 Sale | 2020-01-27 9:19 pm | Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer | 4,473 | $22.17 | $99,169 | 58,803 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-17 Option Award | 2024-06-20 6:19 pm | N/A 2034-06-16 | Gritstone bio Inc. | GRTS | Agarwal Shefali Director | 51,800 | $0 | 51,800 (Direct) | View |
2024-06-07 Option Award | 2024-06-11 4:28 pm | N/A 2034-06-07 | FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director | 40,000 | $0 | 40,000 (Direct) | View |
2023-06-16 Option Award | 2023-06-21 4:47 pm | N/A 2033-06-15 | Gritstone bio Inc. | GRTS | Agarwal Shefali Director | 51,800 | $0 | 51,800 (Direct) | View |
2023-06-06 Option Award | 2023-06-07 4:05 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director | 40,000 | $0 | 40,000 (Direct) | View |
2022-08-12 Disposition | 2022-08-16 6:57 pm | N/A N/A | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 286,539 | $0 | 0 (Direct) | View |
2022-08-09 Exercise | 2022-08-11 8:53 pm | N/A N/A | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 500,000 | $1.39 | 1,129,035 (Direct) | View |
2022-08-09 Tax Withholding | 2022-08-11 8:53 pm | N/A N/A | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 373,154 | $1.39 | 1,129,035 (Direct) | View |
2022-08-09 Exercise | 2022-08-11 8:53 pm | N/A 2032-03-16 | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 500,000 | $0 | 1,129,035 (Direct) | View |
2022-06-17 Option Award | 2022-06-22 5:29 pm | N/A 2032-06-16 | Gritstone bio Inc. | GRTS | Agarwal Shefali Director | 19,000 | $0 | 19,000 (Direct) | View |
2022-06-09 Option Award | 2022-06-13 4:38 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director | 20,543 | $0 | 22,383 (Direct) | View |
2022-03-17 Option Award | 2022-03-21 6:05 pm | N/A 2032-03-16 | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 500,000 | $0 | 658,716 (Direct) | View |
2022-02-28 Option Award | 2022-03-21 6:05 pm | N/A N/A | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 2,331 | $1.2665 | 658,716 (Direct) | View |
2021-06-18 Option Award | 2021-11-19 5:52 pm | N/A 2031-06-17 | Gritstone bio Inc. | GRTS | Agarwal Shefali Director | 937 | $0 | 937 (Direct) | View |
2021-06-01 Option Award | 2021-11-19 5:48 pm | N/A 2031-05-31 | Gritstone bio Inc. | GRTS | Agarwal Shefali Director | 38,000 | $0 | 38,000 (Direct) | View |
2021-08-16 Option Award | 2021-08-18 08:00 am | N/A 2031-08-15 | Epizyme Inc. | EPZM | Agarwal Shefali See Remarks | 341,436 | $0 | 445,777 (Direct) | View |
2021-06-02 Option Award | 2021-06-04 5:26 pm | N/A 2031-06-01 | FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director | 7,015 | $0 | 7,015 (Direct) | View |
2021-02-01 Option Award | 2021-02-02 9:12 pm | N/A 2031-01-31 | Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer | 170,718 | $0 | 246,445 (Direct) | View |
2020-06-25 Option Award | 2020-06-30 08:56 am | N/A N/A | Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer | 6,000 | $0 | 78,611 (Direct) | View |
2020-03-24 Option Award(A) | 2020-06-30 06:15 am | N/A N/A | Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer | 4,000 | $0 | 74,416 (Direct) | View |
2020-05-01 Option Award | 2020-05-05 4:09 pm | N/A 2030-05-01 | FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director | 16,000 | $0 | 16,000 (Direct) | View |
2020-03-24 Option Award | 2020-03-26 9:00 pm | N/A N/A | Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer | 1,575 | $0 | 71,991 (Direct) | View |
2020-02-03 Option Award | 2020-02-05 6:02 pm | N/A 2030-02-02 | Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer | 74,690 | $0 | 133,493 (Direct) | View |
2020-01-23 Option Award | 2020-01-27 9:19 pm | N/A N/A | Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer | 5,000 | $0 | 58,803 (Direct) | View |